help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lapointe, J.
Right arrow Articles by Labrie, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lapointe, J.
Right arrow Articles by Labrie, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Breast Cancer
Hazardous Substances DB
*ESTRADIOL
Endocrinology Vol. 140, No. 1 416-421
Copyright © 1999 by The Endocrine Society

ARTICLES

Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells1

Jacques Lapointe, Andréa Fournier, Virgile Richard and Claude Labrie

Laboratory of Molecular Endocrinology, Centre Hospitalier de l’Université Laval Research Center and Laval University, Ste-Foy, Québec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Dr. Claude Labrie, Laboratory of Molecular Endocrinology, Centre Hospitalier de l’Université Laval Research Center and Laval University, 2705 Laurier Boulevard, Ste-Foy, Québec, Canada G1V 4G2.

Although a large proportion of primary human breast cancers express the androgen receptor, and treatment with androgens exerts beneficial effects in women with breast cancer, the role and especially the mechanism of action of androgens in breast cancer development and growth are not well understood. The potential effect of androgens on bcl-2 protooncogene expression was investigated in a human breast cancer cell line whose proliferation is known to be inhibited by androgens. The estrogen-responsive ZR-75-1 cells were grown in the presence or absence of 5{alpha}-dihydrotestosterone (DHT), alone or in combination with 17ß-estradiol. DHT caused a marked down-regulation of Bcl-2 protein and messenger RNA levels in both the presence and absence of 17ß-estradiol. The inhibitory effect of DHT was completely prevented by coincubation with the pure antiandrogen hydroxyflutamide. The present data indicate that androgens can down-regulate bcl-2 protooncogene levels via an androgen receptor-mediated mechanism, thus providing a novel mechanism for their known inhibitory effect on breast cancer cell growth.




This article has been cited by other articles:


Home page
 FASEB J.Home page
S. N. Birrell, L. M. Butler, J. M. Harris, G. Buchanan, and W. D. Tilley
Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer
FASEB J, August 1, 2007; 21(10): 2285 - 2293.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. F. Macedo, Z. Guo, S. L. Tilghman, G. J. Sabnis, Y. Qiu, and A. Brodie
Role of androgens on mcf-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Cancer Res., August 1, 2006; 66(15): 7775 - 7782.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. M. Callagy, P. D. Pharoah, S. E. Pinder, F. D. Hsu, T. O. Nielsen, J. Ragaz, I. O. Ellis, D. Huntsman, and C. Caldas
Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index
Clin. Cancer Res., April 15, 2006; 12(8): 2468 - 2475.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
W. Somboonporn and S. R. Davis
Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women
Endocr. Rev., June 1, 2004; 25(3): 374 - 388.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Shin and I. M. Verma
BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription
PNAS, June 10, 2003; 100(12): 7201 - 7206.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. L. Zup, H. Carrier, E. M. Waters, A. Tabor, L. Bengston, G. J. Rosen, R. B. Simerly, and N. G. Forger
Overexpression of Bcl-2 Reduces Sex Differences in Neuron Number in the Brain and Spinal Cord
J. Neurosci., March 15, 2003; 23(6): 2357 - 2362.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J.-L. Carsol, S. Gingras, and J. Simard
Synergistic Action of Prolactin (PRL) and Androgen on PRL-Inducible Protein Gene Expression in Human Breast Cancer Cells: A Unique Model for Functional Cooperation between Signal Transducer and Activator of Transcription-5 and Androgen Receptor
Mol. Endocrinol., July 1, 2002; 16(7): 1696 - 1710.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Lapointe and C. Labrie
Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation
Endocrinology, October 1, 2001; 142(10): 4331 - 4338.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K.-C. Choi, S. K. Kang, C.-J. Tai, N. Auersperg, and P. C. K. Leung
Estradiol Up-Regulates Antiapoptotic Bcl-2 Messenger Ribonucleic Acid and Protein in Tumorigenic Ovarian Surface Epithelium Cells
Endocrinology, June 1, 2001; 142(6): 2351 - 2360.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. M. Bruckheimer and N. Kyprianou
Dihydrotestosterone Enhances Transforming Growth Factor-{beta}-Induced Apoptosis in Hormone-Sensitive Prostate Cancer Cells
Endocrinology, June 1, 2001; 142(6): 2419 - 2426.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K.-C. Choi, S. K. Kang, C.-J. Tai, N. Auersperg, and P. C. K. Leung
The Regulation of Apoptosis by Activin and Transforming Growth Factor-{beta} in Early Neoplastic and Tumorigenic Ovarian Surface Epithelium
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2125 - 2135.
[Abstract] [Full Text]

Home page
 Reproductive SciencesHome page
M. J. Jayo, T. C. Register, C. L. Hughes, U. Blas-Machado, E. Sulistiawati, H. Borgerink, and C. S. Johnson
Effects of an Oral Contraceptive Combination With or Without Androgen on Mammary Tissues: A Study in Rats
Reproductive Sciences, July 1, 2000; 7(4): 257 - 265.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
L. Dong, W. Wang, F. Wang, M. Stoner, J. C. Reed, M. Harigai, I. Samudio, M. P. Kladde, C. Vyhlidal, and S. Safe
Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17beta -Estradiol in Breast Cancer Cells
J. Biol. Chem., November 5, 1999; 274(45): 32099 - 32107.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Lapointe and C. Labrie
Identification and Cloning of a Novel Androgen-Responsive Gene, Uridine Diphosphoglucose Dehydrogenase, in Human Breast Cancer Cells
Endocrinology, October 1, 1999; 140(10): 4486 - 4493.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Gutman, S. Couillard, F. Labrie, B. Candas, and C. Labrie
Effects of the Antiestrogen EM-800 (SCH 57050) and Cyclophosphamide Alone and in Combination on Growth of Human ZR-75-1 Breast Cancer Xenografts in Nude Mice
Cancer Res., October 1, 1999; 59(20): 5176 - 5180.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society